ProfileGDS4459 / ENSG00000199921
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 11% 6% 1% 5% 2% 1% 2% 2% 3% 3% 8% 2% 3% 2% 1% 3% 1% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 12.8811
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 22.716
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 31.341
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 42.665
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 51.742
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 61.541
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 71.532
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 81.542
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 91.73
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 101.713
GSM623474group B, liver allograft wedge biopsie placebo treatment 12.528
GSM623475group B, liver allograft wedge biopsie placebo treatment 21.492
GSM623476group B, liver allograft wedge biopsie placebo treatment 31.633
GSM623477group B, liver allograft wedge biopsie placebo treatment 42.322
GSM623478group B, liver allograft wedge biopsie placebo treatment 51.211
GSM623479group B, liver allograft wedge biopsie placebo treatment 62.363
GSM623480group B, liver allograft wedge biopsie placebo treatment 71.871